Nevada Cancer Research Foundation

EIN: 880189404

UEI: VYNWU2X8FMY7

Data as of August 22, 2026

Nevada Cancer Research Foundation9 audit years6 findings
9
Audit Years
6
Total Findings
0
Repeat Findings

FY 2023-05-31

Management decision deadline — for entities that funded this organization

The FAC accepted this audit on December 5, 2023. Under 2 CFR 200.521(d), a pass-through entity that provided federal funds to this organization for this audit period must issue a management decision on these findings by June 5, 2024 (809 days ago).

What is a management decision? →
2023-001
Activities Allowed or Unallowed / Cost Allowability / Cash Management / Period of Performance

While performing tests of the internal controls over expenses, we noted there was no documented evidence of the review and approval for one of the expense samples selected for testing.

Show full finding ▾
Full finding narrative

While performing tests of the internal controls over expenses, we noted there was no documented evidence of the review and approval for one of the expense samples selected for testing.

Corrective Action Plan

Bills will be sent to management to be reviewed and approved through Adobe for their signature. Once the bills have been approved, accounts payable will pay the bills.

About Activities Allowed or Unallowed, Allowable Costs / Cost Principles, Cash Management, Period of Performance →

FY 2020-05-31

FAC accepted this audit on March 23, 2021 — management decision was due September 23, 2021.

2020-001
Procurement & Suspension/Debarment

The policies for procurement do not fully address the requirements of 2 CFR section 200.319(c). The policy should include items such as price analysis, suspension, and debarment testing.

Show full finding ▾
Full finding narrative

The policies for procurement do not fully address the requirements of 2 CFR section 200.319(c). The policy should include items such as price analysis, suspension, and debarment testing.

Corrective Action Plan

A policy has been adopted as of March 02, 2021.

About Procurement and Suspension and Debarment →
2020-002
Procurement & Suspension/Debarment

The Foundation's conflict of interest policy included in the Employee Handbook does not specifically discuss conflicts of interest as it relates to selection, award and administration of contracts.

Show full finding ▾
Full finding narrative

The Foundation's conflict of interest policy included in the Employee Handbook does not specifically discuss conflicts of interest as it relates to selection, award and administration of contracts.

Corrective Action Plan

A policy has been adopted as of March 02, 2021.

About Procurement and Suspension and Debarment →
2020-003
Cash Management

Two of the four selected drawdown packets were unable to be reconciled to the underlying support provided.

Show full finding ▾
Full finding narrative

Two of the four selected drawdown packets were unable to be reconciled to the underlying support provided.

Corrective Action Plan

All bills & invoices will be entered into QuickBooks and reviewed by Management. Management will review the list of bills to be paid and determine the amount of funds to draw down or transferred between the bank accounts.

About Cash Management →
2020-004
Cost Allowability

Three out of the four drawdown packets selected for testing did not use the actual approved indirect cost rate. Two packets used an indirect cost rate of. 33% instead of the approved rate of 32.6% and one packet used an indirect cost rate of 25% instead of the approved rate of 24.70%.

Show full finding ▾
Full finding narrative

Three out of the four drawdown packets selected for testing did not use the actual approved indirect cost rate. Two packets used an indirect cost rate of. 33% instead of the approved rate of 32.6% and one packet used an indirect cost rate of 25% instead of the approved rate of 24.70%.

Corrective Action Plan

Standardized worksheets with the exact percentages will be created and only these worksheets will be used every period.

About Allowable Costs / Cost Principles →

FY 2019-05-31

FAC accepted this audit on November 17, 2019 — management decision was due May 17, 2020.

2019-001
Other

In four clinical trials monitoring audits performed during the year ended May 31, 2019, one unacceptable result requiring re-audit was detected.

Show full finding ▾
Full finding narrative

In four clinical trials monitoring audits performed during the year ended May 31, 2019, one unacceptable result requiring re-audit was detected.

Corrective Action Plan

Adequate training, review and follow up should be more effectively pursued to eliminate adverse events and otherwise unacceptable conditions.

About Other →

Data source: This information comes from the Federal Audit Clearinghouse, the official repository of Single Audit data. All data is public domain. Verify this organization's audit history at fac.gov.

Are you this organization?

Track your findings and corrective action plans across audit cycles.

Start tracking findings →

Do you fund this organization?

Monitor subrecipient audit findings and compliance status.

Start monitoring →

Product

Resources

Legal

Single Audit Intelligence is an independent tool powered by Federal Audit Clearinghouse data. Not affiliated with GSA, OMB, or any federal agency.

© 2026 Single Audit Intelligence. All data is public domain.